We are live on ! Find out more
VIVS

VivoSim Labs
VIVS

119 hedge funds and large institutions have $61.4M invested in VivoSim Labs in 2017 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 37 increasing their positions, 22 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 22

56% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 9

2% more funds holding

Funds holding: 117 → 119 (+2)

0.01% more ownership

Funds ownership: 0.1% → 0.11% (+0.01%)

8% less capital invested

Capital invested by funds: $67M → $61.4M (-$5.63M)

91% less call options, than puts

Call options by funds: $48K | Put options by funds: $527K

Holders
119
Holders Change
+2
Holders Change %
+1.71%
% of All Funds
2.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
37
Reduced
22
Closed
9
Calls
$48K
Puts
$527K
Net Calls
-$479K
Net Calls Change
+$167K

Top Buyers

1
AIM
ARK Investment Management
Florida
+$2.62M
2
Renaissance Technologies
Renaissance Technologies
New York
+$776K
3
Citadel Advisors
Citadel Advisors
Florida
+$710K
4
BlackRock
BlackRock
New York
+$466K
5
Ameriprise
Ameriprise
Minnesota
+$361K

Top Sellers

1
UBS Group
UBS Group
Switzerland
-$1.44M
2
Fidelity International
Fidelity International
Bermuda
-$982K
3
GIP
Granite Investment Partners
California
-$167K
4
AQR Capital Management
AQR Capital Management
Connecticut
-$99K
5
QIM
Quantitative Investment Management
Virginia
-$73K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$17.5M +$466K +875 +3%
Vanguard Group
2
Vanguard Group
Pennsylvania
$10.1M +$190K +357 +2%
AIM
3
ARK Investment Management
Florida
$5.83M +$2.62M +4,924 +82%
State Street
4
State Street
Massachusetts
$3.77M +$7.45K +14 +0.2%
Northern Trust
5
Northern Trust
Illinois
$2.66M -$6.92K -13 -0.3%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$2.21M +$36.7K +69 +2%
UBS Group
7
UBS Group
Switzerland
$1.38M -$1.44M -2,714 -51%
Citadel Advisors
8
Citadel Advisors
Florida
$1.26M +$710K +1,334 +130%
EIM
9
Essex Investment Management
Massachusetts
$1.02M +$219K +411 +27%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$946K -$8.51K -16 -0.9%
Charles Schwab
11
Charles Schwab
California
$917K +$53.7K +101 +6%
Morgan Stanley
12
Morgan Stanley
New York
$826K +$81.4K +153 +11%
Renaissance Technologies
13
Renaissance Technologies
New York
$777K +$776K +1,458 New
TCIM
14
TIAA CREF Investment Management
New York
$695K +$50.5K +95 +8%
Deutsche Bank
15
Deutsche Bank
Germany
$670K +$348K +655 +108%
AFG
16
American Financial Group
Ohio
$558K – – –
TA
17
Teachers Advisors
New York
$554K +$30.9K +58 +6%
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
$464K +$150K +281 +48%
Goldman Sachs
19
Goldman Sachs
New York
$462K +$296K +556 +178%
LFR
20
Lehman Financial Resources
Pennsylvania
$427K +$30.3K +57 +8%
Ameriprise
21
Ameriprise
Minnesota
$404K +$361K +678 +848%
Swiss National Bank
22
Swiss National Bank
Switzerland
$364K – – –
California State Teachers Retirement System (CalSTRS)
23
California State Teachers Retirement System (CalSTRS)
California
$360K -$28.2K -53 -7%
Wells Fargo
24
Wells Fargo
California
$360K +$12.2K +23 +4%
BCM
25
Bridgeway Capital Management
Texas
$341K +$341K +640 New
1
2 3 4 5

VIVS Hedge Fund Activity: Q3 2017 in Review

119 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q3 2017, worth a combined $61.4M — down 8.4% from $67M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new VIVS positions and 9 closed out — a net gain of 5 holders — while 37 added to existing stakes and 22 trimmed.

The largest buyer was ARK Investment Management, adding an estimated $2.62M. The largest seller was UBS Group, cutting an estimated $1.44M.

  • 119 institutional investors held VivoSim Labs (VIVS) as of Q3 2017, up from 117 in Q2 2017.
  • Funds reported $61.4M of VivoSim Labs stock for Q3 2017, down 8.4% quarter-over-quarter.
  • 14 funds opened new VivoSim Labs positions in Q3 2017 and 9 closed out, a net change of +5 holders.
  • The largest VivoSim Labs buyer in Q3 2017 was ARK Investment Management, an estimated $2.62M added.
  • The largest VivoSim Labs seller in Q3 2017 was UBS Group, an estimated $1.44M sold.

Based on aggregated 13F filings for Q3 2017.